Automated Infusion Patent Claims Toothless, Fed. Circ. Finds
The Federal Circuit on Monday found invalid a holding company's patent on an intravenous infusion system because it did not describe the process to control the automated infusion, upholding a lower...To view the full article, register now.
Already a subscriber? Click here to view full article